Lyra Therapeutics (LYRA) EBT Margin (2021 - 2025)
Quarterly EBT Margin fell 9402119.0% to 99271.43% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 7263.32% through Dec 2025, down 117492.0% year-over-year, with the annual reading at 7263.32% for FY2025, 117492.0% down from the prior year.
Lyra Therapeutics' EBT Margin history spans 5 years, with the latest figure at 99271.43% for Q4 2025.
- EBT Margin came in at 99271.43% for Q4 2025, down from 23924.0% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 2545.09% in Q1 2022 to a low of 129290.91% in Q4 2022.
- The 5-year median for EBT Margin is 4846.51% (2021), against an average of 22156.26%.
- Year-over-year, EBT Margin crashed -12426619bps in 2022 and then soared 11892173bps in 2023.
- Lyra Therapeutics' EBT Margin stood at 5024.72% in 2021, then tumbled by -2473bps to 129290.91% in 2022, then surged by 92bps to 10369.18% in 2023, then surged by 49bps to 5250.24% in 2024, then crashed by -1791bps to 99271.43% in 2025.
- Per Business Quant, the three most recent readings for LYRA's EBT Margin are 99271.43% (Q4 2025), 23924.0% (Q3 2025), and 4062.84% (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -6.43% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 41.95% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 23.05% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 18.99% |
| 10 | Lyra Therapeutics | - | - | - | -99,271.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -99,271.43% |
| Sep 30, 2025 | -23,924.00% |
| Jun 30, 2025 | -4,062.84% |
| Mar 31, 2025 | -4,668.31% |
| Dec 31, 2024 | -5,250.24% |
| Sep 30, 2024 | -6,085.13% |
| Jun 30, 2024 | -8,046.66% |
| Mar 31, 2024 | -4,217.67% |
| Dec 31, 2023 | -10,369.18% |
| Sep 30, 2023 | -2,874.08% |
| Jun 30, 2023 | -3,407.42% |
| Mar 31, 2023 | -3,961.22% |
| Dec 31, 2022 | -129,290.91% |
| Sep 30, 2022 | -4,113.09% |
| Jun 30, 2022 | -2,736.38% |
| Mar 31, 2022 | -2,545.09% |
| Dec 31, 2021 | -5,024.72% |
| Sep 30, 2021 | -78,964.29% |